Tag: Vaccine

FDA Approves New and Improved Vaccines to Combat KP.2 Variant

FDA Approves New and Improved Vaccines to Combat KP.2 Variant

FDA announced its decision to authorize updated vaccines to target mainly the KP.2 strain of the virus for its usage in people aged twelve years and above. Its low-dose formulations have also been approved for six months to eleven years ...